Insider trades

Zalevsky Jonathan, Chief Officer of Nektar Therapeutics NKTR, has filed 0 purchases and 22 sales on the open market. Over the past 12 months that comes to a net sale of $563.1K. The latest trade was on 06/15.

Zalevsky Jonathan

Chief R&D Officer
First filing
23/02/17
Trades
31 trades
Buys / sales
0 / 22
12-month net buying
−$563.1K
Last trade
06/15

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/1506/175,538 sh$60.71$336,211.98−26.4%
Open-market sale05/1905/21199 sh$65.51$13,036.49−0.9%
Open-market sale02/1802/20180 sh$73.00$13,140−0.8%
Open-market sale10b5-1 plan01/2001/223,867 sh$35.67$137,935.89−15.3%
Open-market sale25/11/2525/11/251,157 sh$54.28$62,801.96−5.7%
NKTR
Open-market sale10b5-1 plan25/09/0425/09/081,721 sh4 trades$33.52avg.$57,692.51−9.0%
Open-market sale10b5-1 plan25/09/0225/09/04485 sh$30.10$14,598.5−2.5%
Open-market sale25/08/1925/08/21725 sh$26.59$19,277.75−3.6%
Open-market sale25/05/1925/05/2110,712 sh$0.67$7,177.04−3.4%
Open-market sale25/02/1925/02/2110,300 sh$1.01$10,403−3.2%
Open-market sale24/12/1924/12/2051,115 sh$0.94$48,048.1−13.5%
Open-market sale24/11/1924/11/207,785 sh$1.01$7,862.85−3.1%
Open-market sale24/08/1924/08/206,866 sh$1.28$8,788.48−2.7%
Open-market sale24/05/1724/05/207,355 sh$1.75$12,871.25−2.8%
Open-market sale24/02/2024/02/229,014 sh$0.68$6,129.52−3.3%
Open-market sale23/11/1723/11/209,646 sh$0.49$4,726.54−3.4%
Open-market sale23/08/1623/08/179,703 sh$0.78$7,568.34−3.3%
Open-market sale23/05/1623/05/179,791 sh$0.72$7,049.52−3.2%
Open-market sale23/02/1623/02/1710,484 sh$3.00$31,452−3.3%